A new study led by UCLA investigators found that combining zanzalintinib, a targeted therapy drug, and atezolizumab, an ...

The DUO-O trial showed significant improvement in progression-free survival with Imfinzi, Avastin, and Lynparza, but no ...

Results from the phase 2 (dose optimization) part of the REJOICE-Ovarian01 phase 2/3 trial showed that raludotatug deruxtecan (R-DXd) demonstrated clinically meaningful response rates in patients with ...

Copyright: © 2025 The Author(s). Published by Elsevier Ltd. The African Breast Cancer-Disparities in Outcomes (ABC-DO) prospective cohort study was done at eight ...

Prestigious European Society for Medical Oncology Conference “trials-in-progress” sessionPivotal OVATION 3 trial of its DNA-mediated ...

The European Society for Medical Oncology "Living Guideline" for Gastric Cancer suggests that narrow-band imaging or ...

WILSON, N.C. -- You wouldn't know it if she didn't tell you, but Saptosa Foster has been a silent warrior over the past year. She's been battling a disease that didn't run in her family. "Breast ...

Veteran actor Nafisa Ali, known for her memorable role in ‘Life in a Metro’ and many movies, has restarted chemotherapy as ...

Iowa's age-adjusted rate of new cancer cases is second in the U.S., behind only Kentucky. Iowa is also one of just two states where the rate of new cancer cases is rising. Not every form of cancer is ...

Screening and treatment improvements have led to better survival rates. Since the first Breast Cancer Awareness Month initiatives kicked off 40 years ago, major improvements have been made in treating ...

The five-year survival rate has jumped up from around 75% to over 90%. Since the start of Breast Cancer Awareness initiatives in 1985, over 517,000 lives have been saved from better treatment and ...